Apeloa Pharmaceutical Hits Day Low of CNY 14.89 Amid Price Pressure

Apeloa Pharmaceutical Co., Ltd. experienced a notable decline in its stock performance today, with a decrease of 4.82% as of October 22, 2025. The stock reached an intraday low of CNY 14.89, reflecting ongoing challenges in its market position. Over the past week, Apeloa has seen a similar trend, with a 4.88% drop, and its monthly performance shows a decline of 7.82%.
In the context of the broader market, the China Shanghai Composite index has performed positively, gaining 1.36% today and 2.52% over the past month. Apeloa's year-to-date performance stands at -6.52%, significantly underperforming the index, which has risen by 16.84% during the same period.

Financial metrics indicate that while Apeloa has a market capitalization of CNY 18,513 million and a P/E ratio of 19.00, its return on equity is at 14.23%. The company has also reported a high dividend yield of 4.48%. However, the stock's long-term growth appears limited, with net sales growing at an annual rate of 9.83% over the last five years.